Search Results
Cefuroxime Free Acid inquiry | Purity Not Available
Protheragen-ING
Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, gonorrhea, and haemophilus.
More Information Supplier Page7-ACA inquiry | Purity Not Available
Protheragen-ING
7beta-aminocephalosporanic acid is the alpha,beta-unsaturated monocarboxylic acid that is the active nucleus for the synthesis of cephalosporins and intermediates. It is functionally related to a cephalosporanic acid. It is a tautomer of a 7beta-aminocephalosporanic acid zwitterion.
More Information Supplier PageCytarabine Intermediate 2 inquiry | Purity Not Available
Protheragen-ING
Ibrutinib Intermediate 2 inquiry | Purity Not Available
Protheragen-ING
Ibrutinib is a small molecule that acts as an irreversible potent inhibitor of Burton’s tyrosine kinase. It is designated as a targeted covalent drug and presented as a promising activity in B-cell malignancies in clinical trials.
More Information Supplier PageIbrutinib Intermediate 1 inquiry | Purity Not Available
Protheragen-ING
Erlotinib HCL Intermediate 3 inquiry | Purity Not Available
Protheragen-ING
It has a role as an antineoplastic agent, a protein kinase inhibitor and an epidermal growth factor receptor antagonist.
More Information Supplier PageErlotinib HCL Intermediate 2 inquiry | Purity Not Available
Protheragen-ING
A metabolite of Erlotinib. Erlotinib is a tyrosine kinase inhibitor which acts on the epidermal growth factor receptor (EGFR), inhibiting EGFR-associated kinase activity.
More Information Supplier PageErlotinib HCL Intermediate 1 inquiry | Purity Not Available
Protheragen-ING
A metabolite of Erlotinib. Erlotinib is a tyrosine kinase inhibitor which acts on the epidermal growth factor receptor (EGFR), inhibiting EGFR-associated kinase activity.
More Information Supplier Page